Psychiatry Drug Alerts​​

In this month's issue...​
  • Cannabis for Negative Affect
  • Quetiapine and Congenital Malformations
  • Brexanolone for Postpartum Depression            
  • Prazosin for Alcohol Use Disorder
  • Antidepressants and Bleeding Risk
  • Lurasidone and Sexual Function
  • Tianeptine for Geriatric Depression

Child & Adolescent Psychiatry Alerts

In this month's issue...
  • Ketamine for Resistant Depression
  • Asenapine in Bipolar Disorder
  • Enhanced CBT for Panic Disorder
  • Adjunctive tDCS for Anorexia Nervosa
  • Depression Screening Tools
  • ADHD Medication Comparison

MJ Powers & Co publishes monthly newsletters about the efficacy and safety of drugs and therapeutics. The Alerts contain summaries, from a wide variety of journals, that can help you solve a problem, warn you about safety, or reassure you about efficacy. Not only will you receive the latest research findings, but also useful tools to help you judge research quality, evaluate study independence, and guide you with statistics. 

The Alerts Newsletters are timely and thorough, and you can be assured of objectivity because MJ Powers & Co is independent. There is no sponsorship associated with any of our newsletters, and we accept no advertising. In addition, as a subscriber you will be eligible to enroll in our CME program, which your colleagues consistently rate as "excellent" and "practice changing". 
Login In
Psychiatry Alerts NOS​​​

In this month's issue...
  • Substance Abuse and Bipolar Recovery
  • Suicide Risk Factors in Bipolar Disorder
  • Self-Injury: Online Self-Help
  • Adjunctive VNS in Depression
  • Biological Aging and Depression
  • Smartphone Apps for Mental Health

​​Primary Care Drug Alerts​​​

In this month's issue​...
  • SGLT2 Inhibitors and Necrotizing Fasciitis
  • Sulfonylureas: Safety of Switching
  • Fremanezumab for Migraine Prevention            
  • Aspirin: Body Weight and Dosing
  • Antidepressants and Bleeding Risk